Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Dietary Carbohydrate (Amount and Type) in the Prevention and Management of Diabetes: A statement by the American Diabetes Association
The STEP (Semaglutide Treatment Effect in People with obesity) trial program showed average weight reductions of approximately 15% of initial body weight over 68 weeks in individuals without diabetes, with somewhat lower reductions (about 9-10%) in those with type 2 diabetes
People taking semaglutide who also consume alcohol should be particularly vigilant about this, as alcohol is an independent risk factor for pancreatitis that can compound any GLP-1-related risk
Archived from the original on October 8, 2020
